Avidity Science, which is backed by ShoreView, has acquired the Cascada Laboratory Water Purification product line from Pall Corporation. No financial terms were disclosed. The Cascada product line is a provider of water purification solutions used in life sciences research throughout Asia.
The Partners of ShoreView are pleased to announce that Avidity Science, a ShoreView portfolio company, has acquired the Cascada Laboratory Water Purification (“Cascada”) product line from Pall Corporation, a Danaher Company.
The Cascada product line represents a full suite of benchtop water purification solutions used in life sciences research throughout Asia. In conjunction with the acquisition, Avidity established manufacturing and distribution operations in Jiaxing, China. These investments expand Avidity’s portfolio of water purification products and provide regional capabilities to support customers in one of the leading international research markets.
Avidity Science is a worldwide leader in water purification systems and laboratory equipment for scientific research and healthcare facilities. Since ShoreView invested in Avidity Science in 2016, the Company has completed four strategic acquisitions.
ShoreView assisted Avidity Science in its acquisition of the Cascada product line. To learn more about Avidity Science, please visit its website at https://www.avidityscience.com.
Founded in 2002, ShoreView is a Minneapolis-based private equity firm that has raised over $1.3 billion of committed capital across four funds. ShoreView partners with family or entrepreneurial-owned companies across many sectors, including engineered products, distribution, industrial services, business services, healthcare, and niche consumer products. Shoreview structures a variety of acquisition, recapitalization and build-up transactions, typically in businesses with revenues ranging between $20 million and $300 million.